Page last updated: 2024-08-21

myristic acid and Obesity

myristic acid has been researched along with Obesity in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's3 (33.33)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Cao, Y; Du, K; Faizy, A; Lu, X; Luo, Z; Piomelli, D; Shan, J; Sun, L; Sun, Q; Yang, Q; Zhang, K1
Ai, W; Bhatt, S; Desouza, CV; Gopal, T; Harris, EN; Kumar, N; Saraswathi, V; Talmon, GA1
Brink, R; Galic, S; Hoque, A; Kemp, BE; Kozlov, N; Ling, NXY; Loh, K; McAloon, LM; Murray-Segal, L; Negoita, F; Neopane, K; Oakhill, JS; Ovens, AJ; Sakamoto, K; Sanders, MJ; Scott, JW; Steinberg, GR; Tjin, G; Yu, D1
Bao, C; Chen, S; Li, Y; Li, Z; Liang, S; Liu, B; Ren, F; Shi, W; Yan, H; Yuan, Y; Zhang, H1
Chen, Y; Du, S; Feng, R; Li, C; Li, Y; Luo, C; Niu, Y; Okekunle, AP; Zi, T1
Anderson, BM; Grasso, P; Novakovic, ZM1
Alvim, S; Del Carmen B Molina, M; Drehmer, M; Duncan, BB; Lotufo, PA; Pereira, MA; Schmidt, MI1
Dennis, AL; Frayn, KN; Harnden, KE; Hodson, L; Humphreys, SM; Micklem, KJ; Neville, MJ; Roberts, R1
Döppler, H; Müller, G; Pfizenmaier, K; Storz, P; Wernig, A1

Other Studies

9 other study(ies) available for myristic acid and Obesity

ArticleYear
Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity.
    Metabolism: clinical and experimental, 2022, Volume: 131

    Topics: Angiotensin-Converting Enzyme 2; Animals; Chromatography, Liquid; COVID-19; Dimyristoylphosphatidylcholine; HEK293 Cells; Humans; Lung; Mice; Myristic Acid; Obesity; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface-Active Agents; Tandem Mass Spectrometry

2022
Myristic Acid Supplementation Aggravates High Fat Diet-Induced Adipose Inflammation and Systemic Insulin Resistance in Mice.
    Biomolecules, 2022, 05-24, Volume: 12, Issue:6

    Topics: Adipokines; Adipose Tissue; Animals; Diet, High-Fat; Dietary Supplements; Glucose; Inflammation; Insulin; Insulin Resistance; Insulins; Liver; Mice; Mice, Inbred C57BL; Myristic Acid; Obesity; Resistin

2022
Blocking AMPK β1 myristoylation enhances AMPK activity and protects mice from high-fat diet-induced obesity and hepatic steatosis.
    Cell reports, 2022, 12-20, Volume: 41, Issue:12

    Topics: AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Fatty Liver; Mice; Mice, Inbred C57BL; Myristic Acid; Obesity; Phosphorylation; Protein Phosphatase 2C; Protein Processing, Post-Translational

2022
Non-Cardiotoxic Tetradecanoic Acid-2,4-Dinitrophenol Ester Nanomicelles in Microneedles Exert Potent Anti-Obesity Effect by Regulating Adipocyte Browning and Lipogenesis.
    Small (Weinheim an der Bergstrasse, Germany), 2023, Volume: 19, Issue:39

    Topics: 2,4-Dinitrophenol; Adipocytes; Animals; Dinitrophenols; Esters; Lipogenesis; Mice; Myristic Acid; Obesity

2023
Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case - control study.
    Lipids in health and disease, 2017, Sep-04, Volume: 16, Issue:1

    Topics: Adult; Body Mass Index; Case-Control Studies; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; gamma-Linolenic Acid; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Myristic Acid; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Thinness

2017
Myristic acid conjugation of [D-Leu-4]-OB3, a biologically active leptin-related synthetic peptide amide, significantly improves its pharmacokinetic profile and efficacy.
    Peptides, 2014, Volume: 62

    Topics: Animals; Diabetes Mellitus; Humans; Leptin; Male; Mice; Mice, Inbred NOD; Mice, Obese; Myristic Acid; Obesity; Peptide Fragments; Peptides; Pharmacokinetics

2014
Associations of dairy intake with glycemia and insulinemia, independent of obesity, in Brazilian adults: the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    The American journal of clinical nutrition, 2015, Volume: 101, Issue:4

    Topics: Adult; Aged; Blood Glucose; Brazil; Cross-Sectional Studies; Dairy Products; Diabetes Mellitus, Type 2; Fasting; Female; Glycated Hemoglobin; Humans; Insulin; Linear Models; Logistic Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Myristic Acid; Nutrition Assessment; Obesity; Prospective Studies; Risk Factors; Surveys and Questionnaires

2015
Markers of de novo lipogenesis in adipose tissue: associations with small adipocytes and insulin sensitivity in humans.
    Diabetologia, 2009, Volume: 52, Issue:5

    Topics: Adipocytes; Adipose Tissue; Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fatty Acids; Fatty Acids, Nonesterified; Gene Expression Regulation; Humans; Insulin Resistance; Lipids; Mitochondria; Myristic Acid; Obesity; Palmitic Acid; Polymerase Chain Reaction; Reference Values; RNA, Messenger; Stearic Acids; Triglycerides

2009
Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake.
    European journal of biochemistry, 1999, Volume: 266, Issue:1

    Topics: Animals; Biological Transport, Active; Cells, Cultured; Deoxyglucose; Diabetes Mellitus, Type 2; Down-Regulation; Fatty Acids, Nonesterified; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Microsomes; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Myristic Acid; Obesity; Palmitic Acid; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction; Tumor Necrosis Factor-alpha

1999